Dynamic Profiling of Cell Free Tumour DNA in Aggressive B‐Cell Lymphoma From Diagnosis to Transformation at Relapse
These data further support the potential utility of molecular lymphoma profiling by ctDNA analysis and the predictive value of EMR as reported by independent groups. We also posit that ctDNA alone is insufficient to diagnose late relapses, where shared mutations may associate with differential histopathology.
Authors
- Daniella Brasacchio (ORCID: https://orcid.org/0000-0001-5956-9611)
- Aditya Tedjaseputra (ORCID: https://orcid.org/0000-0001-6224-1940)
- Jonathan Wong (ORCID: https://orcid.org/0000-0003-2974-8023)
- Galina Polekhina (ORCID: https://orcid.org/0000-0001-9535-9291)
- Mark Waltham (ORCID: https://orcid.org/0000-0001-9623-8133)
- Pranav Dorwal (ORCID: https://orcid.org/0000-0002-7755-8745)
- Gareth Peter Gregory (ORCID: https://orcid.org/0000-0002-4170-0682)
- Jake Shortt (ORCID: https://orcid.org/0000-0003-3185-6488)
- Belinda Maher (ORCID: https://orcid.org/0000-0002-8900-6876)
- Stephen Opat (ORCID: https://orcid.org/0000-0002-0308-6458)
- Tessa Potezny (ORCID: https://orcid.org/0000-0003-1124-9656)
Institutions
- The University of Melbourne (AU)
- Peter MacCallum Cancer Centre (AU)
- Monash Health (AU)
- Monash University (AU)
Publication Details
- Journal
- eJHaem
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1002/jha2.70126
- Citations
- 1
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- Amgen
- Monash University
- National Health and Medical Research Council